Skip to main content
. 2022 Feb 20;3:100125. doi: 10.1016/j.cccb.2022.100125

Table 1.

Population characteristics of participants.

Scan 1n=195 Scan 2n=136
Women, % 103 (52.8) 72 (52.9)
Age in years, mean (± SD) 77.3 (2.5) 80.0 (2.6)
History stroke (incl. cortical infarctions), % 13 (6.8) 10 (7.5)
History DM2, % 20 (10.3) 14 (10.3)
History CVD, % 40 (21.3) 26 (19.8)
MMSE, mean (±SD) 28.6 (1.5) 28.9 (1.3)
Smoking status,
Never / Former/ Current %
14 (7.2) /3 (1.5) /178 (91.3) 6 (4.4) /3 (2.2)/119 (87.5)
Antihypertension medication use, % 79 (40.5) 75 (55.2)
Antiplatelet use, % 52 (36.3) 35 (27.3)
Antithrombotic use, % 60 (30.8) 43 (33.6)
SBP, mean (±SD) 151.2 (21.5) 156.4 (18.3)
DBP, mean (±SD) 81.8 (11.6) 79.5 (11.0)
Cholesterol, mean (±SD) 5.4 (1.2) 5.2 (1.1)
LDL, mean (±SD) 3.3 (1.1) 2.8 (1.0)
HDL, mean(±SD) 1.6 (0.4) 1.6 (0.5)

Abbreviations: SD= standard deviation, DM2=diabetes mellitus type 2, CVD = cardiovascular disease, MMSE=mini mental state examination, SBP=systolic blood pressure, DBP=diastolic blood pressure, LDL=low-density lipoprotein, HDL=high-density lipoprotein.

Missings scan 1/2: Sex 0/0, age: 0/0, history of stroke 3/2, DM2 0/0, CVD 7/5, MMSE 1/2, smoking status 0/8, antiplatelet use 0/8, antithrombotic use 0/8, SBP 1/9, DBP 1/9, cholesterol 35/19, LDL 40/19, HDL 37/19.